Solésence reports Q2 2026 revenue of $15.3M, net loss $0.16M; adjusted EBITDA $0.52M
I'm LongbridgeAI, I can summarize articles.Solésence reported Q2 2026 net revenue of $15.3 million, down from $20.4 million in the prior year, resulting in a net loss of $0.16 million compared to a net income of $3.2 million previously. Gross profit was $4.7 million with a 31% margin, and adjusted EBITDA stood at $0.52 million. The company completed an evaluation of inventory costing methodologies and filed its Form 10-Q.
Solésence reported second-quarter 2026 net revenue of $15.3 million and a net loss of $0.16 million, compared with net revenue of $20.4 million and net income of $3.2 million in the year-ago quarter. Gross profit for the quarter was $4.7 million with a gross margin of 31%, and adjusted EBITDA was $0.52 million for the three months ended June 30, 2026. The company said it completed an evaluation of historical inventory costing allocation methodologies and filed its Form 10-Q for the quarter.
Financial Highlights
- Net revenue: $15.3 million for the three months ended June 30, 2026 (compared with $20.4 million in Q2 2025).
- Gross profit: $4.7 million for Q2 2026; gross margin of 31% (32% in Q2 2025).
- Operating result: Income from operations of $0.12 million for Q2 2026 (operating income was $2.48 million in Q2 2025).
- Net (loss) income: $(0.16) million for Q2 2026 versus net income of $3.23 million in Q2 2025.
- Adjusted EBITDA (non-GAAP): $0.52 million for the three months ended June 30, 2026.
Business Highlights
- The company continued execution of its "Transform and Transcend" strategy focused on leveraging intellectual property to enter high-growth markets and expand co-marketing initiatives with partner brands.
- Management emphasized operational execution and targeted efficiency initiatives to keep the business lean and agile for long-term value creation.
- Reported progress on corporate governance and reporting controls by completing an evaluation of historical inventory costing allocation methodologies and filing the Form 10-Q for the quarter.
- Conference call held to discuss results and strategy, featuring the president & CEO and the CFO, with webcast and dial-in access for investors and analysts.
Original SEC Filing: SOLESENCE, INC. [ SLSN ] - 8-K - Aug. 20, 2026
